Alterations in total sialic acid (TSA), total proteins (TP) and TSA/TP ratio in cancer patients

Biomedical Research

Volumn 22, Issue 4, 2011, Pages 492-494

  Durgawale, Pushpa ^a   Sontakke, Ajit ^a   Shukla, P S ^b   Durgawale, Pratik ^c   Chougule, Pandurang ^a  

^a KRISHNA INSTITUTE OF MEDICAL SCIENCES   (India)

^b Manipal Institute Medical Sciences   (India)

^c KIT's College of Engineering   (India)

Author keywords

Cancer; Serum protein; Sialic acid

Indexed keywords

SIALIC ACID; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; CANCER GROWTH; CANCER PATIENT; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; PATIENT MONITORING; PROTEIN BLOOD LEVEL; RELIABILITY; SENSITIVITY AND SPECIFICITY;

EID: 80053934815     PISSN: 0970938X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Marth E, Flaschka G, Stiegler S, Mose J. Sialic acid as a marker for differentiation between benign and malignant intracranial tumors. Clinica Chimica Acta. 1988; 176: 251-258.
2. Macbeth RAI, Bekei. JG. Plasma glycoprotein in various disease states including carcinoma. Cancer Research. 1962; 23: 1170.
3. Winnzler R.J. Methods of biochemical analysis II. In-terscience Publisher, New York. P. 279, 1958.
4. Erbil K, Jones J, Klee G. Use and limitations of serum total and lipid bound sialic acid concentrations as markers for colorectal cancer. Cancer.1985; 55: 404-409.
5. Katopodis N, Hirshaut Y, Geller N, Stock C. Lipid associated sialic acid test for the detection of human cancer. Cancer Research.1982; 42: 5270-5275.
6. Plucinsky M, Riley W, Michael, PJ, Alhadeff J. Total and lipid associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement, Cancer.1986; 58: 2680-2685.
7. Mark C, Plucinsky W, Michael RJP, Jack A. Total and lipid-Associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement. Cancer. 1986. 12: 2680-2685.
8. Varley H: Practical clinical Biochemistry IV Edition; Arnold Heinemann Pub. India. P. 172, 1975.
9. Hakomori S. Tumor associated carbohydrate antigens. Ann Rev Immunol. 1984; 2:103-126.
10. Arivazhagan S, Kavitha K, Nagini S. Glycocojugate profile in plasma and erythrocytes of gastric cancer patients. Ind J Physiol Pharmacol. 1998; 42: 123-126.
11. Tewarson S, Mittal V, Singh M, Gupta G. Serum sialic acid - an important cancer marker. Ind J Cancer. 1993; 30: 125-131.
12. Silver H, Rengel D, Morto I. Serum sialic acid elevations in malignant melanoma patients. Cancer 1978; 41:1497-1499.
13. Singh R, Sur B, Agarwal S, Ramaraju B. Serum sialic acid in malignancy. Ind J Med Res.1967; 55: 3: 270-273.
14. Raval G, Parekh L, Ptel D, Jha F, Sainge R, Patel P. Clinical usefulness of alterations in sialic acid, Sialy-transferase and sialoproteins in breast cancer. Ind J Clin Bio 2004; 19: 60-72.